Association between radiosensitivity and molecular subtypes in patients with early-stage breast cancer and lymph node-negative status

SUNG-HSIN KUOCHIUN-SHENG HUANG2021-02-232021-02-2320172218-676Xhttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85038253117&doi=10.21037%2ftcr.2017.11.09&partnerID=40&md5=53787345bc023c6c2256593d0cc54d35https://scholars.lib.ntu.edu.tw/handle/123456789/549418[SDGs]SDG3aromatase inhibitor; tamoxifen; trastuzumab; breast cancer; cancer combination chemotherapy; cancer radiotherapy; cancer recurrence; cancer size; cancer survival; clinical trial; early cancer; Editorial; human; lymph node; overall survival; radiosensitivityAssociation between radiosensitivity and molecular subtypes in patients with early-stage breast cancer and lymph node-negative statuseditorial10.21037/tcr.2017.11.092-s2.0-85038253117